Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures
- 1 August 2016
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (8) , 4717-4721
Abstract
To improve antibiotic prescribing, we sought to establish the probability of a resistant organism in urine culture given a previous resistant culture in a setting endemic for multidrug-resistant (MDR) organisms. We performed a retrospective analysis of inpatients with paired positive urine cultures. We focused on ciprofloxacin-resistant (cipro r ) Gram-negative bacteria, extended-spectrum-beta-lactamase (ESBL)-producing Enterobacteriaceae , carbapenem-resistant Enterobacteriaceae (CRE), and carbapenem-resistant nonfermenters (CRNF). Comparisons were made between the frequency of each resistance phenotype following a previous culture with the same phenotype and the overall frequency of that phenotype, and odds ratios (ORs) were calculated. We performed a regression to assess the effects of other variables on the likelihood of a repeat resistant culture. A total of 4,409 patients (52.5% women; median age, 70 years) with 19,546 paired positive urine cultures were analyzed. The frequencies of cipro r bacteria, ESBL-producing Enterobacteriaceae , CRE, and CRNF among all cultures were 47.7%, 30.6%, 1.7%, and 2.6%, respectively. ORs for repeated resistance phenotypes were 1.87, 3.19, 48.25, and 19.02 for cipro r bacteria, ESBL-producing Enterobacteriaceae , CRE, and CRNF, respectively ( P < 0.001 for all). At 1 month, the frequencies of repeated resistance phenotypes were 77.4%, 66.4%, 57.1%, and 33.3% for cipro r bacteria, ESBL-producing Enterobacteriaceae , CRE, and CRNF, respectively. Increasing time between cultures and the presence of an intervening nonresistant culture significantly reduced the chances of a repeat resistant culture. Associations were statistically significant over the duration of follow-up (60 months) for CRE and for up to 6 months for all other pathogens. Knowledge of microbiology results in the six preceding months may assist with antibiotic stewardship and improve the appropriateness of empirical treatment for urinary tract infections (UTIs).Keywords
Funding Information
- European Commission (Health-F3-2011-278348)
This publication has 11 references indexed in Scilit:
- Two Simple Rules for Improving the Accuracy of Empiric Treatment of Multidrug-Resistant Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 2015
- Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control StudyInfection Control & Hospital Epidemiology, 2015
- Predictive Utility of Prior Positive Urine CulturesClinical Infectious Diseases, 2014
- Impact of extended‐spectrum β‐lactamase–producing organisms on clinical and economic outcomes in patients with urinary tract infectionJournal of Hospital Medicine, 2014
- Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009–2011)Journal of Chemotherapy, 2013
- Secular Trends in Gram-Negative Resistance among Urinary Tract Infection Hospitalizations in the United States, 2000–2009Infection Control & Hospital Epidemiology, 2013
- In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010Antimicrobial Agents and Chemotherapy, 2012
- Trimethoprim-Sulfamethoxazole May No Longer Be Acceptable for the Treatment of Acute Uncomplicated Cystitis in the United StatesClinical Infectious Diseases, 2011
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trialJournal of Antimicrobial Chemotherapy, 2006